

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.55817667 |
| 2 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.47452087 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.81331981 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.81331981 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 4.75273302 |
| 6 | indolalkylamine catabolic process (GO:0046218) | 4.75122676 |
| 7 | tryptophan catabolic process (GO:0006569) | 4.75122676 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 4.75122676 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.65035086 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 4.65035086 |
| 11 | tryptophan metabolic process (GO:0006568) | 4.43080709 |
| 12 | kynurenine metabolic process (GO:0070189) | 4.34279115 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.29429095 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.14993479 |
| 15 | B cell receptor signaling pathway (GO:0050853) | 4.14842974 |
| 16 | regulation of B cell differentiation (GO:0045577) | 4.06044061 |
| 17 | bile acid biosynthetic process (GO:0006699) | 4.05114795 |
| 18 | regulation of mast cell degranulation (GO:0043304) | 4.04324861 |
| 19 | response to peptidoglycan (GO:0032494) | 4.04308629 |
| 20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.01362395 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 3.95306054 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.92079462 |
| 23 | detection of other organism (GO:0098543) | 3.84729437 |
| 24 | positive regulation of granulocyte differentiation (GO:0030854) | 3.82539992 |
| 25 | detection of bacterium (GO:0016045) | 3.80504584 |
| 26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.76904583 |
| 27 | megakaryocyte development (GO:0035855) | 3.75801887 |
| 28 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.74266418 |
| 29 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.72812162 |
| 30 | regulation of fibrinolysis (GO:0051917) | 3.71611198 |
| 31 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.69624218 |
| 32 | urea cycle (GO:0000050) | 3.69044295 |
| 33 | urea metabolic process (GO:0019627) | 3.69044295 |
| 34 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.62269162 |
| 35 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.62269162 |
| 36 | Peyers patch development (GO:0048541) | 3.61566895 |
| 37 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.61566895 |
| 38 | glyoxylate metabolic process (GO:0046487) | 3.60586802 |
| 39 | complement activation, alternative pathway (GO:0006957) | 3.59937716 |
| 40 | positive regulation by symbiont of host defense response (GO:0052509) | 3.59633023 |
| 41 | modulation by symbiont of host defense response (GO:0052031) | 3.59633023 |
| 42 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.59633023 |
| 43 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.59633023 |
| 44 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.59633023 |
| 45 | modulation by symbiont of host immune response (GO:0052553) | 3.59633023 |
| 46 | alpha-linolenic acid metabolic process (GO:0036109) | 3.57110488 |
| 47 | regulation of gamma-delta T cell activation (GO:0046643) | 3.55944031 |
| 48 | protein carboxylation (GO:0018214) | 3.55616092 |
| 49 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.55616092 |
| 50 | NAD biosynthetic process (GO:0009435) | 3.52534992 |
| 51 | high-density lipoprotein particle remodeling (GO:0034375) | 3.51784944 |
| 52 | B cell mediated immunity (GO:0019724) | 3.50073932 |
| 53 | blood coagulation, intrinsic pathway (GO:0007597) | 3.48023410 |
| 54 | regulation of protein activation cascade (GO:2000257) | 3.47244404 |
| 55 | sulfur amino acid catabolic process (GO:0000098) | 3.43765243 |
| 56 | nitrogen cycle metabolic process (GO:0071941) | 3.40413519 |
| 57 | ribosomal small subunit assembly (GO:0000028) | 3.40315389 |
| 58 | regulation of leukocyte degranulation (GO:0043300) | 3.39135900 |
| 59 | cellular biogenic amine catabolic process (GO:0042402) | 3.38765076 |
| 60 | amine catabolic process (GO:0009310) | 3.38765076 |
| 61 | neutrophil activation (GO:0042119) | 3.37050442 |
| 62 | aromatic amino acid family metabolic process (GO:0009072) | 3.36210687 |
| 63 | regulation of cholesterol esterification (GO:0010872) | 3.35836123 |
| 64 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.30033895 |
| 65 | bile acid metabolic process (GO:0008206) | 3.29898720 |
| 66 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.28500559 |
| 67 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.28500559 |
| 68 | cysteine metabolic process (GO:0006534) | 3.28419495 |
| 69 | positive regulation of B cell differentiation (GO:0045579) | 3.26241195 |
| 70 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.25696904 |
| 71 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.25696904 |
| 72 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.24827765 |
| 73 | positive regulation of mast cell degranulation (GO:0043306) | 3.24827765 |
| 74 | regulation of complement activation (GO:0030449) | 3.24692038 |
| 75 | regulation of mast cell activation (GO:0033003) | 3.24625134 |
| 76 | indolalkylamine metabolic process (GO:0006586) | 3.23618491 |
| 77 | leukocyte degranulation (GO:0043299) | 3.23350962 |
| 78 | amino-acid betaine metabolic process (GO:0006577) | 3.19940872 |
| 79 | phospholipid efflux (GO:0033700) | 3.18704831 |
| 80 | regulation of triglyceride catabolic process (GO:0010896) | 3.17261861 |
| 81 | imidazole-containing compound metabolic process (GO:0052803) | 3.15593378 |
| 82 | mature B cell differentiation involved in immune response (GO:0002313) | 3.14663263 |
| 83 | detection of external biotic stimulus (GO:0098581) | 3.14004226 |
| 84 | positive thymic T cell selection (GO:0045059) | 3.13351109 |
| 85 | positive regulation of mast cell activation (GO:0033005) | 3.11966980 |
| 86 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.11778991 |
| 87 | negative regulation of cell killing (GO:0031342) | 3.11778991 |
| 88 | regulation of erythrocyte differentiation (GO:0045646) | 3.11731921 |
| 89 | glycine metabolic process (GO:0006544) | 3.11160133 |
| 90 | protein-lipid complex remodeling (GO:0034368) | 3.08967449 |
| 91 | macromolecular complex remodeling (GO:0034367) | 3.08967449 |
| 92 | plasma lipoprotein particle remodeling (GO:0034369) | 3.08967449 |
| 93 | cellular extravasation (GO:0045123) | 3.06816129 |
| 94 | reverse cholesterol transport (GO:0043691) | 3.05687661 |
| 95 | endothelium development (GO:0003158) | 3.04121130 |
| 96 | ethanol oxidation (GO:0006069) | 3.03417643 |
| 97 | myeloid cell activation involved in immune response (GO:0002275) | 3.03319592 |
| 98 | serine family amino acid catabolic process (GO:0009071) | 3.02845759 |
| 99 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.00065520 |
| 100 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.99740896 |
| 101 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.98872349 |
| 102 | regulation of granulocyte differentiation (GO:0030852) | 2.98826917 |
| 103 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.98471147 |
| 104 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.95294732 |
| 105 | bile acid and bile salt transport (GO:0015721) | 2.95259696 |
| 106 | response to muramyl dipeptide (GO:0032495) | 2.95230060 |
| 107 | low-density lipoprotein particle remodeling (GO:0034374) | 2.94793357 |
| 108 | DNA deamination (GO:0045006) | 2.93143997 |
| 109 | protein activation cascade (GO:0072376) | 2.90559051 |
| 110 | granulocyte activation (GO:0036230) | 2.90164065 |
| 111 | benzene-containing compound metabolic process (GO:0042537) | 2.90154966 |
| 112 | complement activation, classical pathway (GO:0006958) | 2.89749551 |
| 113 | negative regulation of cholesterol transport (GO:0032375) | 2.87681993 |
| 114 | negative regulation of sterol transport (GO:0032372) | 2.87681993 |
| 115 | response to protozoan (GO:0001562) | 2.87136704 |
| 116 | alpha-amino acid catabolic process (GO:1901606) | 2.87004862 |
| 117 | urate metabolic process (GO:0046415) | 2.86700893 |
| 118 | platelet dense granule organization (GO:0060155) | 2.86373048 |
| 119 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.85500329 |
| 120 | regulation of hypersensitivity (GO:0002883) | 2.83694786 |
| 121 | tyrosine metabolic process (GO:0006570) | 2.83422209 |
| 122 | cofactor catabolic process (GO:0051187) | 2.81918289 |
| 123 | definitive hemopoiesis (GO:0060216) | 2.81533302 |
| 124 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.80904322 |
| 125 | response to host immune response (GO:0052572) | 2.80904322 |
| 126 | opsonization (GO:0008228) | 2.79719413 |
| 127 | leukocyte aggregation (GO:0070486) | 2.79430733 |
| 128 | serine family amino acid biosynthetic process (GO:0009070) | 2.78218522 |
| 129 | pinocytosis (GO:0006907) | 2.77605723 |
| 130 | response to interferon-beta (GO:0035456) | 2.77323138 |
| 131 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.77290596 |
| 132 | complement activation (GO:0006956) | 2.76802969 |
| 133 | regulation of humoral immune response (GO:0002920) | 2.76605592 |
| 134 | valine metabolic process (GO:0006573) | 2.74952109 |
| 135 | coenzyme catabolic process (GO:0009109) | 2.74739184 |
| 136 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.74659107 |
| 137 | aldehyde catabolic process (GO:0046185) | 2.74355356 |
| 138 | acylglycerol homeostasis (GO:0055090) | 2.73859193 |
| 139 | triglyceride homeostasis (GO:0070328) | 2.73859193 |
| 140 | mature B cell differentiation (GO:0002335) | 2.71839469 |
| 141 | detection of biotic stimulus (GO:0009595) | 2.71619114 |
| 142 | killing of cells of other organism (GO:0031640) | 2.71037431 |
| 143 | disruption of cells of other organism (GO:0044364) | 2.71037431 |
| 144 | regulation of regulated secretory pathway (GO:1903305) | 2.70343336 |
| 145 | serine family amino acid metabolic process (GO:0009069) | 2.70109228 |
| 146 | regulation of B cell apoptotic process (GO:0002902) | 2.69980109 |
| 147 | positive regulation of interleukin-17 production (GO:0032740) | 2.66647387 |
| 148 | myeloid cell development (GO:0061515) | 2.66109164 |
| 149 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.65663328 |
| 150 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.65663328 |
| 151 | plasma lipoprotein particle assembly (GO:0034377) | 2.65470463 |
| 152 | macrophage activation involved in immune response (GO:0002281) | 2.65459178 |
| 153 | arginine metabolic process (GO:0006525) | 2.64616452 |
| 154 | negative regulation of interleukin-12 production (GO:0032695) | 2.63892575 |
| 155 | regulation of antigen processing and presentation (GO:0002577) | 2.63049749 |
| 156 | thrombin receptor signaling pathway (GO:0070493) | 2.61991025 |
| 157 | regulation of interleukin-17 production (GO:0032660) | 2.60684176 |
| 158 | fibrinolysis (GO:0042730) | 2.59807457 |
| 159 | homocysteine metabolic process (GO:0050667) | 2.59570167 |
| 160 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.57883402 |
| 161 | primary alcohol catabolic process (GO:0034310) | 2.57229626 |
| 162 | negative regulation of granulocyte differentiation (GO:0030853) | 2.57097188 |
| 163 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.55841402 |
| 164 | response to host (GO:0075136) | 2.55841402 |
| 165 | response to host defenses (GO:0052200) | 2.55841402 |
| 166 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.55817779 |
| 167 | germinal center formation (GO:0002467) | 2.55405761 |
| 168 | pyridine-containing compound biosynthetic process (GO:0072525) | 2.55345417 |
| 169 | defense response to protozoan (GO:0042832) | 2.55321515 |
| 170 | lysine catabolic process (GO:0006554) | 2.55238440 |
| 171 | lysine metabolic process (GO:0006553) | 2.55238440 |
| 172 | acute-phase response (GO:0006953) | 2.55197699 |
| 173 | granulocyte differentiation (GO:0030851) | 2.54870011 |
| 174 | mast cell activation (GO:0045576) | 2.54746775 |
| 175 | positive regulation of B cell activation (GO:0050871) | 2.54352489 |
| 176 | immunoglobulin mediated immune response (GO:0016064) | 2.53965617 |
| 177 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.53757445 |
| 178 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.50473888 |
| 179 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.50473888 |
| 180 | histamine secretion (GO:0001821) | 2.48826314 |
| 181 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.47695784 |
| 182 | regulation of superoxide anion generation (GO:0032928) | 2.47451229 |
| 183 | detection of molecule of bacterial origin (GO:0032490) | 2.46593334 |
| 184 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.43942538 |
| 185 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.42846336 |
| 186 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.42759642 |
| 187 | response to thyroid hormone (GO:0097066) | 2.41450345 |
| 188 | erythrocyte maturation (GO:0043249) | 2.40505322 |
| 189 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.40369576 |
| 190 | negative regulation of B cell apoptotic process (GO:0002903) | 2.39205179 |
| 191 | macrophage activation (GO:0042116) | 2.38174754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.95859262 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.13951635 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.08840965 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.81492024 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.66950505 |
| 6 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 3.47995039 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.19604071 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.93088669 |
| 9 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.81066327 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.78021756 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.74479165 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.65309654 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.64722669 |
| 14 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.62360351 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.55650050 |
| 16 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.54335404 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.46314836 |
| 18 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.44037274 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.35734261 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.28814842 |
| 21 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.25589888 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.25501433 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.21241879 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.20571374 |
| 25 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18806610 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.09859642 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.05517168 |
| 28 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98541610 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.95588732 |
| 30 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90953389 |
| 31 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90926451 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.90722200 |
| 33 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.86155437 |
| 34 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83537887 |
| 35 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.81972005 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69170210 |
| 37 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.66936617 |
| 38 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.65660680 |
| 39 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.64057590 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.62825104 |
| 41 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60556724 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58945569 |
| 43 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58933244 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57647696 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57604527 |
| 46 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.56282981 |
| 47 | MYC_22102868_ChIP-Seq_BL_Human | 1.55687666 |
| 48 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.54986922 |
| 49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.53957010 |
| 50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.53660027 |
| 51 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.53502560 |
| 52 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52006685 |
| 53 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.51725433 |
| 54 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49281027 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.49191235 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.48906277 |
| 57 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48021923 |
| 58 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.41993715 |
| 59 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36652416 |
| 60 | MAF_26560356_Chip-Seq_TH1_Human | 1.35610586 |
| 61 | * MYB_26560356_Chip-Seq_TH1_Human | 1.33989761 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.33948931 |
| 63 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33885848 |
| 64 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.32664600 |
| 65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32210602 |
| 66 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.30732188 |
| 67 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.30483679 |
| 68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30123826 |
| 69 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.29573703 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.28993226 |
| 71 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.27416260 |
| 72 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.26559463 |
| 73 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.23862583 |
| 74 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21931259 |
| 75 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.19534655 |
| 76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18642881 |
| 77 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18063152 |
| 78 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.17880001 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17680868 |
| 80 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.16408913 |
| 81 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.16343076 |
| 82 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.15767091 |
| 83 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.15655626 |
| 84 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.15195463 |
| 85 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.14432252 |
| 86 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.14257318 |
| 87 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14122410 |
| 88 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13559108 |
| 89 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.13106438 |
| 90 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11529757 |
| 91 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.11288333 |
| 92 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.10901626 |
| 93 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10642364 |
| 94 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10114180 |
| 95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10006610 |
| 96 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.09423004 |
| 97 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08918362 |
| 98 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08498174 |
| 99 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07638233 |
| 100 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.06727344 |
| 101 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06347605 |
| 102 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06064240 |
| 103 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05959575 |
| 104 | * SPI1_20517297_ChIP-Seq_HL60_Human | 1.05578536 |
| 105 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05050367 |
| 106 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03107814 |
| 107 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02847920 |
| 108 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00727518 |
| 109 | P300_27268052_Chip-Seq_Bcells_Human | 0.99202737 |
| 110 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.98300592 |
| 111 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97321410 |
| 112 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.95348166 |
| 113 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94077279 |
| 114 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.93949174 |
| 115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93710981 |
| 116 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93654793 |
| 117 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93494061 |
| 118 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.93340142 |
| 119 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.91478189 |
| 120 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.90659869 |
| 121 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89045728 |
| 122 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86531875 |
| 123 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85883753 |
| 124 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.85729188 |
| 125 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84874169 |
| 126 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.84606131 |
| 127 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83887836 |
| 128 | MAF_26560356_Chip-Seq_TH2_Human | 0.83466257 |
| 129 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.82651516 |
| 130 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.81873116 |
| 131 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.81382386 |
| 132 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81195354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.86589293 |
| 2 | MP0005360_urolithiasis | 4.28977526 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.02678003 |
| 4 | MP0005365_abnormal_bile_salt | 3.94162783 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.20901174 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.91073089 |
| 7 | MP0009840_abnormal_foam_cell | 2.58602288 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.54822069 |
| 9 | MP0003252_abnormal_bile_duct | 2.52720784 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.41239966 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.36209177 |
| 12 | MP0009785_altered_susceptibility_to | 2.30621895 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.20175568 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.20026629 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.17741769 |
| 16 | MP0003724_increased_susceptibility_to | 2.05621141 |
| 17 | MP0003436_decreased_susceptibility_to | 2.03648847 |
| 18 | MP0000685_abnormal_immune_system | 1.92462206 |
| 19 | MP0005083_abnormal_biliary_tract | 1.92096314 |
| 20 | MP0005025_abnormal_response_to | 1.85616737 |
| 21 | MP0005671_abnormal_response_to | 1.85240247 |
| 22 | MP0005397_hematopoietic_system_phenotyp | 1.82332341 |
| 23 | MP0001545_abnormal_hematopoietic_system | 1.82332341 |
| 24 | MP0001800_abnormal_humoral_immune | 1.81633108 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.73825251 |
| 26 | MP0002419_abnormal_innate_immunity | 1.69532646 |
| 27 | MP0000609_abnormal_liver_physiology | 1.67506487 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.66176703 |
| 29 | MP0001764_abnormal_homeostasis | 1.64231260 |
| 30 | MP0001853_heart_inflammation | 1.61924785 |
| 31 | MP0008469_abnormal_protein_level | 1.57933295 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.56988240 |
| 33 | MP0002723_abnormal_immune_serum | 1.55810747 |
| 34 | MP0005075_abnormal_melanosome_morpholog | 1.52739385 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.51563329 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.50671501 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.50292463 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 1.49483712 |
| 39 | MP0010368_abnormal_lymphatic_system | 1.47114864 |
| 40 | MP0005387_immune_system_phenotype | 1.46264014 |
| 41 | MP0001790_abnormal_immune_system | 1.46264014 |
| 42 | MP0005332_abnormal_amino_acid | 1.45796799 |
| 43 | MP0003828_pulmonary_edema | 1.45115929 |
| 44 | MP0003868_abnormal_feces_composition | 1.44817801 |
| 45 | MP0009764_decreased_sensitivity_to | 1.44511782 |
| 46 | MP0005451_abnormal_body_composition | 1.43404659 |
| 47 | MP0003186_abnormal_redox_activity | 1.43309548 |
| 48 | MP0009697_abnormal_copulation | 1.41327723 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.41234349 |
| 50 | MP0002166_altered_tumor_susceptibility | 1.40826451 |
| 51 | MP0001819_abnormal_immune_cell | 1.40537575 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.39475894 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.39347187 |
| 54 | * MP0002398_abnormal_bone_marrow | 1.39042712 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.35246303 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.29379431 |
| 57 | * MP0000716_abnormal_immune_system | 1.28880349 |
| 58 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.28729554 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.27326115 |
| 60 | * MP0000598_abnormal_liver_morphology | 1.25851877 |
| 61 | MP0002118_abnormal_lipid_homeostasis | 1.25467490 |
| 62 | MP0009763_increased_sensitivity_to | 1.22575191 |
| 63 | MP0002722_abnormal_immune_system | 1.22520215 |
| 64 | * MP0002429_abnormal_blood_cell | 1.19799215 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.19679260 |
| 66 | MP0003195_calcinosis | 1.19021057 |
| 67 | MP0001851_eye_inflammation | 1.16420472 |
| 68 | MP0004147_increased_porphyrin_level | 1.15764657 |
| 69 | MP0004019_abnormal_vitamin_homeostasis | 1.14563903 |
| 70 | MP0008004_abnormal_stomach_pH | 1.10713908 |
| 71 | MP0006082_CNS_inflammation | 1.10596755 |
| 72 | MP0005174_abnormal_tail_pigmentation | 1.08576070 |
| 73 | MP0003763_abnormal_thymus_physiology | 1.06449857 |
| 74 | MP0008260_abnormal_autophagy | 1.06386772 |
| 75 | MP0001873_stomach_inflammation | 1.04774727 |
| 76 | MP0002405_respiratory_system_inflammati | 1.03752241 |
| 77 | MP0002132_abnormal_respiratory_system | 1.03191995 |
| 78 | MP0000858_altered_metastatic_potential | 0.99170388 |
| 79 | MP0009333_abnormal_splenocyte_physiolog | 0.99118808 |
| 80 | MP0000490_abnormal_crypts_of | 0.98784719 |
| 81 | MP0003075_altered_response_to | 0.97523130 |
| 82 | MP0009643_abnormal_urine_homeostasis | 0.96694776 |
| 83 | MP0009278_abnormal_bone_marrow | 0.96272427 |
| 84 | MP0006054_spinal_hemorrhage | 0.94708811 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.92554824 |
| 86 | MP0002006_tumorigenesis | 0.91639327 |
| 87 | MP0006036_abnormal_mitochondrial_physio | 0.91633026 |
| 88 | MP0005058_abnormal_lysosome_morphology | 0.90741992 |
| 89 | MP0003300_gastrointestinal_ulcer | 0.88659159 |
| 90 | MP0004883_abnormal_blood_vessel | 0.87820892 |
| 91 | MP0009379_abnormal_foot_pigmentation | 0.86465708 |
| 92 | MP0008057_abnormal_DNA_replication | 0.86056907 |
| 93 | MP0003866_abnormal_defecation | 0.85289035 |
| 94 | MP0003693_abnormal_embryo_hatching | 0.85192666 |
| 95 | MP0004782_abnormal_surfactant_physiolog | 0.84282594 |
| 96 | MP0002009_preneoplasia | 0.84086557 |
| 97 | * MP0000681_abnormal_thyroid_gland | 0.84069720 |
| 98 | MP0000015_abnormal_ear_pigmentation | 0.84010144 |
| 99 | MP0005220_abnormal_exocrine_pancreas | 0.83995056 |
| 100 | MP0009642_abnormal_blood_homeostasis | 0.82966230 |
| 101 | MP0004947_skin_inflammation | 0.81317075 |
| 102 | MP0001533_abnormal_skeleton_physiology | 0.79108829 |
| 103 | MP0003172_abnormal_lysosome_physiology | 0.78633363 |
| 104 | MP0003011_delayed_dark_adaptation | 0.77060466 |
| 105 | MP0002019_abnormal_tumor_incidence | 0.76782066 |
| 106 | * MP0003943_abnormal_hepatobiliary_system | 0.76073986 |
| 107 | MP0005636_abnormal_mineral_homeostasis | 0.75319943 |
| 108 | MP0000249_abnormal_blood_vessel | 0.74370073 |
| 109 | MP0005164_abnormal_response_to | 0.74031830 |
| 110 | MP0001663_abnormal_digestive_system | 0.72671989 |
| 111 | MP0003638_abnormal_response/metabolism_ | 0.72061705 |
| 112 | MP0008873_increased_physiological_sensi | 0.71486943 |
| 113 | MP0008007_abnormal_cellular_replicative | 0.71136358 |
| 114 | MP0000343_altered_response_to | 0.69831164 |
| 115 | MP0005647_abnormal_sex_gland | 0.69341092 |
| 116 | MP0002095_abnormal_skin_pigmentation | 0.68869974 |
| 117 | MP0002998_abnormal_bone_remodeling | 0.68380901 |
| 118 | MP0000678_abnormal_parathyroid_gland | 0.66962986 |
| 119 | MP0003303_peritoneal_inflammation | 0.65903385 |
| 120 | MP0005166_decreased_susceptibility_to | 0.64677259 |
| 121 | MP0005376_homeostasis/metabolism_phenot | 0.64138740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.39995935 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 4.81100203 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.38014715 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.37468093 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.30242438 |
| 6 | Joint hemorrhage (HP:0005261) | 4.10434506 |
| 7 | Chronic obstructive pulmonary disease (HP:0006510) | 4.05102090 |
| 8 | Obstructive lung disease (HP:0006536) | 4.05102090 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 3.83281862 |
| 10 | Complement deficiency (HP:0004431) | 3.74820344 |
| 11 | Recurrent fungal infections (HP:0002841) | 3.62914555 |
| 12 | Xanthomatosis (HP:0000991) | 3.59947912 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.56474566 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 3.53038362 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 3.42941160 |
| 16 | Thrombocytosis (HP:0001894) | 3.41698565 |
| 17 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.41143207 |
| 18 | Stomatitis (HP:0010280) | 3.41132459 |
| 19 | Acute lymphatic leukemia (HP:0006721) | 3.39980152 |
| 20 | Abnormality of B cell number (HP:0010975) | 3.38916678 |
| 21 | Gingival bleeding (HP:0000225) | 3.26707990 |
| 22 | Epistaxis (HP:0000421) | 3.22778120 |
| 23 | Prolonged bleeding time (HP:0003010) | 3.14672194 |
| 24 | Reduced antithrombin III activity (HP:0001976) | 3.11562776 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.11064777 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 3.10877977 |
| 27 | Abnormality of complement system (HP:0005339) | 3.07105490 |
| 28 | Orchitis (HP:0100796) | 3.04504000 |
| 29 | B lymphocytopenia (HP:0010976) | 3.02109518 |
| 30 | Recurrent bacterial skin infections (HP:0005406) | 3.01146795 |
| 31 | Hyperbilirubinemia (HP:0002904) | 3.00440786 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.98657416 |
| 33 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.97110580 |
| 34 | Impaired platelet aggregation (HP:0003540) | 2.92731106 |
| 35 | Abnormal platelet function (HP:0011869) | 2.92731106 |
| 36 | Granulocytopenia (HP:0001913) | 2.92401598 |
| 37 | Hyperammonemia (HP:0001987) | 2.92230183 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 2.91376140 |
| 39 | Mediastinal lymphadenopathy (HP:0100721) | 2.90802854 |
| 40 | Petechiae (HP:0000967) | 2.89966057 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.87215567 |
| 42 | Recurrent abscess formation (HP:0002722) | 2.81186068 |
| 43 | IgM deficiency (HP:0002850) | 2.78354653 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.77982438 |
| 45 | Recurrent cutaneous fungal infections (HP:0011370) | 2.77982438 |
| 46 | Myositis (HP:0100614) | 2.77545312 |
| 47 | Fat malabsorption (HP:0002630) | 2.77354741 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.76588587 |
| 49 | Optic neuritis (HP:0100653) | 2.74238090 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 2.74238090 |
| 51 | Hypercholesterolemia (HP:0003124) | 2.74079351 |
| 52 | Acute hepatic failure (HP:0006554) | 2.70503967 |
| 53 | Vasculitis (HP:0002633) | 2.68699954 |
| 54 | Hypochromic anemia (HP:0001931) | 2.65392292 |
| 55 | Episodic fever (HP:0001954) | 2.63620969 |
| 56 | Spontaneous hematomas (HP:0007420) | 2.63331216 |
| 57 | Hypochromic microcytic anemia (HP:0004840) | 2.62776598 |
| 58 | Hypoglycemic coma (HP:0001325) | 2.61806668 |
| 59 | Abnormality of methionine metabolism (HP:0010901) | 2.61742380 |
| 60 | Urticaria (HP:0001025) | 2.61354627 |
| 61 | Increased IgE level (HP:0003212) | 2.59213413 |
| 62 | Acute myeloid leukemia (HP:0004808) | 2.57285341 |
| 63 | Arterial thrombosis (HP:0004420) | 2.55762876 |
| 64 | Chest pain (HP:0100749) | 2.55088597 |
| 65 | Hypolipoproteinemia (HP:0010981) | 2.54761299 |
| 66 | Microcytic anemia (HP:0001935) | 2.54679928 |
| 67 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.54557032 |
| 68 | Aplastic anemia (HP:0001915) | 2.54408579 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.53974073 |
| 70 | Abnormal hemoglobin (HP:0011902) | 2.49735603 |
| 71 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.49558153 |
| 72 | Abnormality of the prostate (HP:0008775) | 2.48239412 |
| 73 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.47499639 |
| 74 | Leukocytosis (HP:0001974) | 2.46215313 |
| 75 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.46099741 |
| 76 | Menorrhagia (HP:0000132) | 2.45981869 |
| 77 | Fatigue (HP:0012378) | 2.45388098 |
| 78 | Ketosis (HP:0001946) | 2.44622631 |
| 79 | Conjugated hyperbilirubinemia (HP:0002908) | 2.44465841 |
| 80 | Chronic otitis media (HP:0000389) | 2.43958781 |
| 81 | Steatorrhea (HP:0002570) | 2.42256592 |
| 82 | Thrombophlebitis (HP:0004418) | 2.41998495 |
| 83 | Glomerulonephritis (HP:0000099) | 2.41809500 |
| 84 | Abnormality of the peritoneum (HP:0002585) | 2.41777811 |
| 85 | Osteomyelitis (HP:0002754) | 2.39937401 |
| 86 | Delayed CNS myelination (HP:0002188) | 2.38562166 |
| 87 | Polygenic inheritance (HP:0010982) | 2.37660288 |
| 88 | Spontaneous abortion (HP:0005268) | 2.37074125 |
| 89 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.35839091 |
| 90 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.35764951 |
| 91 | Abnormality of T cell physiology (HP:0011840) | 2.35710261 |
| 92 | Epidermoid cyst (HP:0200040) | 2.34985228 |
| 93 | Recurrent skin infections (HP:0001581) | 2.34787907 |
| 94 | Hypertensive crisis (HP:0100735) | 2.34433167 |
| 95 | Abnormality of T cells (HP:0002843) | 2.33519706 |
| 96 | Viral hepatitis (HP:0006562) | 2.31187217 |
| 97 | Seborrheic dermatitis (HP:0001051) | 2.29801653 |
| 98 | Generalized aminoaciduria (HP:0002909) | 2.29314927 |
| 99 | Autoimmune thrombocytopenia (HP:0001973) | 2.28266640 |
| 100 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.27455756 |
| 101 | Purpura (HP:0000979) | 2.25155669 |
| 102 | Abnormality of nucleobase metabolism (HP:0010932) | 2.23384475 |
| 103 | Meningitis (HP:0001287) | 2.22306149 |
| 104 | Abnormality of iron homeostasis (HP:0011031) | 2.22071509 |
| 105 | Agammaglobulinemia (HP:0004432) | 2.20278052 |
| 106 | Hyperglycinemia (HP:0002154) | 2.19866942 |
| 107 | Abnormal number of erythroid precursors (HP:0012131) | 2.19136092 |
| 108 | Increased serum ferritin (HP:0003281) | 2.17761555 |
| 109 | Increased IgM level (HP:0003496) | 2.16110303 |
| 110 | Inflammation of the large intestine (HP:0002037) | 2.14760465 |
| 111 | Colitis (HP:0002583) | 2.14593702 |
| 112 | Skin rash (HP:0000988) | 2.12934079 |
| 113 | Recurrent viral infections (HP:0004429) | 2.12775713 |
| 114 | Vacuolated lymphocytes (HP:0001922) | 2.11791199 |
| 115 | Pulmonary embolism (HP:0002204) | 2.11682469 |
| 116 | Peritonitis (HP:0002586) | 2.10503853 |
| 117 | Acanthocytosis (HP:0001927) | 2.10346107 |
| 118 | Keratoconjunctivitis sicca (HP:0001097) | 2.09953045 |
| 119 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.09707316 |
| 120 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.08779295 |
| 121 | Pallor (HP:0000980) | 2.07688064 |
| 122 | Gastrointestinal inflammation (HP:0004386) | 2.07475078 |
| 123 | Panhypogammaglobulinemia (HP:0003139) | 2.04932641 |
| 124 | Eosinophilia (HP:0001880) | 2.04429639 |
| 125 | Encephalitis (HP:0002383) | 2.04392835 |
| 126 | Myocardial infarction (HP:0001658) | 2.04142848 |
| 127 | Pulmonary infiltrates (HP:0002113) | 2.03938293 |
| 128 | Type I transferrin isoform profile (HP:0003642) | 2.03921664 |
| 129 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.03529813 |
| 130 | Dicarboxylic aciduria (HP:0003215) | 2.03529813 |
| 131 | Hepatosplenomegaly (HP:0001433) | 2.02948628 |
| 132 | Severe combined immunodeficiency (HP:0004430) | 1.98850332 |
| 133 | Hypoalphalipoproteinemia (HP:0003233) | 1.97701655 |
| 134 | Elevated hepatic transaminases (HP:0002910) | 1.97316273 |
| 135 | Periodontitis (HP:0000704) | 1.97257406 |
| 136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95033244 |
| 137 | Hypoplasia of the thymus (HP:0000778) | 1.94777308 |
| 138 | Esophageal varix (HP:0002040) | 1.94635473 |
| 139 | Increased mean platelet volume (HP:0011877) | 1.93664969 |
| 140 | Abnormality of serum amino acid levels (HP:0003112) | 1.92603399 |
| 141 | Gingivitis (HP:0000230) | 1.91841450 |
| 142 | Abnormality of macrophages (HP:0004311) | 1.90743898 |
| 143 | Cellulitis (HP:0100658) | 1.90741546 |
| 144 | Polycythemia (HP:0001901) | 1.90697093 |
| 145 | Poikilocytosis (HP:0004447) | 1.90318940 |
| 146 | Hyperglycinuria (HP:0003108) | 1.89661651 |
| 147 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.89260863 |
| 148 | Sepsis (HP:0100806) | 1.88833575 |
| 149 | Reticulocytopenia (HP:0001896) | 1.88607326 |
| 150 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.88119257 |
| 151 | Abnormality of glycine metabolism (HP:0010895) | 1.88119257 |
| 152 | Abnormal platelet volume (HP:0011876) | 1.87898890 |
| 153 | Pustule (HP:0200039) | 1.87077379 |
| 154 | Amyloidosis (HP:0011034) | 1.86982848 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.32533147 |
| 2 | TAOK3 | 3.05440761 |
| 3 | KIT | 2.84229946 |
| 4 | FLT3 | 2.79547007 |
| 5 | ERN1 | 2.69074526 |
| 6 | BCKDK | 2.52787759 |
| 7 | STK16 | 2.41013257 |
| 8 | BTK | 2.29526778 |
| 9 | TEC | 2.24554592 |
| 10 | BLK | 2.21990694 |
| 11 | IRAK4 | 2.10445262 |
| 12 | TGFBR2 | 2.03430166 |
| 13 | CSF1R | 2.03209528 |
| 14 | TIE1 | 2.02605429 |
| 15 | TBK1 | 2.00678873 |
| 16 | TYK2 | 2.00526051 |
| 17 | MAP2K3 | 1.95005946 |
| 18 | BMPR2 | 1.93791325 |
| 19 | KDR | 1.86385323 |
| 20 | IRAK3 | 1.73275191 |
| 21 | TGFBR1 | 1.72961174 |
| 22 | ACVR1B | 1.71127570 |
| 23 | PRPF4B | 1.68087097 |
| 24 | PIM2 | 1.59097787 |
| 25 | MAP3K14 | 1.58503356 |
| 26 | ZAP70 | 1.56682478 |
| 27 | FGFR4 | 1.54140801 |
| 28 | IKBKE | 1.54023779 |
| 29 | NME2 | 1.50602996 |
| 30 | JAK3 | 1.41871596 |
| 31 | IKBKB | 1.33638545 |
| 32 | EEF2K | 1.32655536 |
| 33 | BRSK2 | 1.30018384 |
| 34 | SYK | 1.28697763 |
| 35 | TXK | 1.22055314 |
| 36 | MATK | 1.21455792 |
| 37 | WEE1 | 1.18857907 |
| 38 | MAPK11 | 1.16959760 |
| 39 | MAP3K13 | 1.16950968 |
| 40 | PIK3CG | 1.11952756 |
| 41 | LYN | 1.09795835 |
| 42 | TESK2 | 1.03488466 |
| 43 | DYRK3 | 1.02462160 |
| 44 | PIM1 | 1.02416277 |
| 45 | TRPM7 | 1.01572517 |
| 46 | PKN2 | 1.00726041 |
| 47 | RPS6KA4 | 0.99736156 |
| 48 | MAP3K1 | 0.99662882 |
| 49 | CDK12 | 0.91562507 |
| 50 | MAP3K6 | 0.90145925 |
| 51 | MAP2K6 | 0.89553184 |
| 52 | NEK9 | 0.86677516 |
| 53 | FES | 0.85849496 |
| 54 | LRRK2 | 0.84379965 |
| 55 | MUSK | 0.84078318 |
| 56 | MAPK4 | 0.83545363 |
| 57 | NLK | 0.82042938 |
| 58 | STK10 | 0.81879598 |
| 59 | SCYL2 | 0.81132132 |
| 60 | MAP3K7 | 0.81106219 |
| 61 | GRK6 | 0.80495993 |
| 62 | NUAK1 | 0.79133081 |
| 63 | RPS6KB2 | 0.76808321 |
| 64 | VRK1 | 0.76241324 |
| 65 | CDK7 | 0.75954342 |
| 66 | MAPK15 | 0.74402353 |
| 67 | LCK | 0.73074139 |
| 68 | MAP3K11 | 0.72289290 |
| 69 | TNIK | 0.72135813 |
| 70 | JAK1 | 0.72121592 |
| 71 | ADRBK2 | 0.72058533 |
| 72 | HCK | 0.71687788 |
| 73 | MAPKAPK3 | 0.71246445 |
| 74 | RAF1 | 0.70541468 |
| 75 | ITK | 0.70526279 |
| 76 | PRKCQ | 0.70406190 |
| 77 | SMG1 | 0.70360108 |
| 78 | TAOK2 | 0.70270990 |
| 79 | JAK2 | 0.69765110 |
| 80 | CSK | 0.69341261 |
| 81 | IRAK1 | 0.69205184 |
| 82 | MAP3K12 | 0.68506398 |
| 83 | HIPK2 | 0.67336682 |
| 84 | CHUK | 0.65338229 |
| 85 | IRAK2 | 0.65252783 |
| 86 | PDK1 | 0.65186712 |
| 87 | NEK2 | 0.63321294 |
| 88 | CDK4 | 0.63094024 |
| 89 | PDPK1 | 0.62740510 |
| 90 | SIK1 | 0.61807488 |
| 91 | MARK3 | 0.61665428 |
| 92 | INSRR | 0.60776639 |
| 93 | EIF2AK3 | 0.60691524 |
| 94 | CDK8 | 0.59487875 |
| 95 | VRK2 | 0.58347790 |
| 96 | PRKG2 | 0.57923353 |
| 97 | STK4 | 0.56996249 |
| 98 | ABL2 | 0.54783736 |
| 99 | MAP3K5 | 0.54213875 |
| 100 | CDK9 | 0.53965642 |
| 101 | RPS6KL1 | 0.53272170 |
| 102 | RPS6KC1 | 0.53272170 |
| 103 | FGFR3 | 0.53183993 |
| 104 | RET | 0.53119086 |
| 105 | CDK6 | 0.52823236 |
| 106 | MAP3K10 | 0.52396434 |
| 107 | GRK1 | 0.52139398 |
| 108 | RIPK4 | 0.51905284 |
| 109 | DAPK1 | 0.50226096 |
| 110 | CLK1 | 0.50152225 |
| 111 | PRKAA2 | 0.50148579 |
| 112 | EIF2AK1 | 0.49353269 |
| 113 | CDK19 | 0.49039730 |
| 114 | MAPK7 | 0.47684132 |
| 115 | BUB1 | 0.47377988 |
| 116 | DYRK1B | 0.45608347 |
| 117 | CAMKK2 | 0.45024034 |
| 118 | DAPK2 | 0.44943019 |
| 119 | PASK | 0.44253813 |
| 120 | PRKD2 | 0.43823813 |
| 121 | MAP2K2 | 0.43579302 |
| 122 | MKNK1 | 0.43194669 |
| 123 | TNK2 | 0.42267560 |
| 124 | RPS6KA6 | 0.42247776 |
| 125 | MAPK3 | 0.41645278 |
| 126 | MAP3K3 | 0.40801070 |
| 127 | PAK4 | 0.40747561 |
| 128 | ATR | 0.40019915 |
| 129 | MAPK12 | 0.37866028 |
| 130 | MAPKAPK5 | 0.36417260 |
| 131 | ABL1 | 0.35783120 |
| 132 | FGR | 0.35051269 |
| 133 | MAPKAPK2 | 0.33841027 |
| 134 | KSR2 | 0.32972145 |
| 135 | PTK6 | 0.32439346 |
| 136 | MAP4K2 | 0.31878683 |
| 137 | MAP2K4 | 0.30006012 |
| 138 | MAP3K2 | 0.29131164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.02245207 |
| 2 | Asthma_Homo sapiens_hsa05310 | 2.98969828 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.96571807 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.86755945 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.75393553 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.65189752 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.52082660 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.38008641 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.34251700 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.33681560 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.18038737 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.16602714 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.12828965 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.09444110 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.06118929 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.99025560 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.98336827 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.97456952 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.97139646 |
| 20 | Platelet activation_Homo sapiens_hsa04611 | 1.94521947 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.94011708 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.88726598 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.74264181 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.71659678 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.69071480 |
| 26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.69058901 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.67844947 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.64333379 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.63617808 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.61756924 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.59351860 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.54631738 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.52973016 |
| 34 | DNA replication_Homo sapiens_hsa03030 | 1.50961532 |
| 35 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.49601517 |
| 36 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.49568728 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.49553422 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47952360 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43749356 |
| 40 | Sulfur relay system_Homo sapiens_hsa04122 | 1.42533974 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.41579052 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41464875 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.40740288 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34816069 |
| 45 | Ribosome_Homo sapiens_hsa03010 | 1.33335761 |
| 46 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.29649990 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.28686417 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.28041455 |
| 49 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.23486971 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.22455340 |
| 51 | Malaria_Homo sapiens_hsa05144 | 1.19316486 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.16355251 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.14933335 |
| 54 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.12738956 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11656880 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.11213931 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10630065 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09445558 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.05722253 |
| 60 | Base excision repair_Homo sapiens_hsa03410 | 1.03722593 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02235632 |
| 62 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.99837779 |
| 63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.98283701 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97016678 |
| 65 | Mismatch repair_Homo sapiens_hsa03430 | 0.93159864 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92322034 |
| 67 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.90897409 |
| 68 | * Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.89853542 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.89495316 |
| 70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87015221 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 0.84794428 |
| 72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.84548926 |
| 73 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.84333970 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82595108 |
| 75 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.81937033 |
| 76 | Leishmaniasis_Homo sapiens_hsa05140 | 0.81649940 |
| 77 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.81266330 |
| 78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.80756516 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77842402 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.76483700 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75471020 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75465258 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73525385 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73213630 |
| 85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72998038 |
| 86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72265604 |
| 87 | Shigellosis_Homo sapiens_hsa05131 | 0.71642406 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.71191570 |
| 89 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69407080 |
| 90 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.69274827 |
| 91 | Homologous recombination_Homo sapiens_hsa03440 | 0.69087131 |
| 92 | Bile secretion_Homo sapiens_hsa04976 | 0.68216195 |
| 93 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.67985143 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.66384765 |
| 95 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.66366028 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65870832 |
| 97 | Measles_Homo sapiens_hsa05162 | 0.65647834 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65251000 |
| 99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65097222 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65094101 |
| 101 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64199771 |
| 102 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62691060 |
| 103 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.62318988 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.60710451 |
| 105 | Lysine degradation_Homo sapiens_hsa00310 | 0.60682082 |
| 106 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.58957590 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.57919496 |
| 108 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57674619 |
| 109 | Lysosome_Homo sapiens_hsa04142 | 0.57458220 |
| 110 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57363155 |
| 111 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56614951 |
| 112 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.54857570 |
| 113 | Legionellosis_Homo sapiens_hsa05134 | 0.54838788 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | 0.53609373 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52911296 |
| 116 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.52764730 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52539378 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51745124 |
| 119 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51332341 |
| 120 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50507888 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47533130 |
| 122 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.46920532 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46514211 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44714652 |
| 125 | Apoptosis_Homo sapiens_hsa04210 | 0.44437355 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44190670 |
| 127 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.41749089 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41342861 |
| 129 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41166614 |
| 130 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41015899 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39977697 |
| 132 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39899387 |
| 133 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.39196553 |
| 134 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.39190516 |
| 135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39100893 |
| 136 | Influenza A_Homo sapiens_hsa05164 | 0.38720472 |
| 137 | Insulin resistance_Homo sapiens_hsa04931 | 0.38106731 |
| 138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37737551 |
| 139 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37604411 |
| 140 | Protein export_Homo sapiens_hsa03060 | 0.37284232 |
| 141 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36387732 |
| 142 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36230628 |
| 143 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35438572 |
| 144 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35380946 |
| 145 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32523445 |
| 146 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32286705 |
| 147 | Amoebiasis_Homo sapiens_hsa05146 | 0.31702421 |
| 148 | RNA degradation_Homo sapiens_hsa03018 | 0.31100967 |
| 149 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.30944347 |
| 150 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.28800785 |
| 151 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27103423 |
| 152 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26992835 |
| 153 | Salmonella infection_Homo sapiens_hsa05132 | 0.26729179 |
| 154 | Olfactory transduction_Homo sapiens_hsa04740 | 0.25701694 |

